English
2021 Latest Design Narcotine Hydrochloride - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu Featured Image
  • 2021 Latest Design Narcotine Hydrochloride - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu

2021 Latest Design Narcotine Hydrochloride - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

We also offer product sourcing and flight consolidation services. We've got our personal factory and sourcing office. We can easily present you with almost every style of merchandise linked to our merchandise range for Argatroban Intermediate, L-Alanine, 161596-47-0, Let's cooperate hand in hand to jointly make a beautiful future. We sincerely welcome you to visit our company or contact us for cooperation!
2021 Latest Design Narcotine Hydrochloride - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu Detail:

Commercial Supply Molnupiravir and Related Intermediates with High Quality
Uridine CAS 58-96-8
Cytidine CAS 65-46-3
Molnupiravir N-1 CAS 2346620-55-9
Molnupiravir (EIDD-2801) CAS 2349386-89-4

Chemical Name Molnupiravir (EIDD-2801)
Synonyms MK-4482; β-D-N4-Hydroxycytidine-5′-isopropyl ester; ((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
CAS Number 2349386-89-4
CAT Number RF-API97
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C13H19N3O7
Molecular Weight 329.31
Solubility Soluble in DMSO
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-White Powder
Identification IR Sample Spectrum corresponds to that of reference standard
Identification HPLC The retention time of the major peak of the sample solution corresponds to that of the standard solution
Related Substances  
Impurity A ≤0.15%
Impurity B ≤0.15%
Any Unspecified Impurity   ≤0.15%
Total Unspecified Impurities ≤0.30%
Total Impurities ≤0.50%
Residual Solvents  
N-Heptane ≤5000ppm
Ethanol ≤5000ppm
Isopropyl Acetate ≤5000ppm
Acetonitrile ≤410ppm
Methylene Dichloride ≤600ppm
Acetone ≤5000ppm
Isopropanol ≤5000ppm
Water Content (K.F) ≤0.50%
Residue on Ignition ≤0.10% 
Optical Rotation -7.5° to -9.5° (C=0.5, Methanol)
Heavy Metals ≤10ppm
Purity / Analysis Method ≥99.5% (230nm)
Assay / Analysis Method 98.0%~102.0% (HPLC on dried basis)
Shelf Life 24 Months
Test Standard Enterprise Standard
Usage API, Molnupiravir (EIDD-2801) COVID-19 Inhibitor

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1

Molnupiravir (EIDD-2801, MK-4482) is an orally bioavailable prodrug of the ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) with broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and the causative agent of COVID-19. Molnupiravir is sold under the brand name Lagevrio and generically as emorivir. Molnupiravir has been shown to improve pulmonary function, decrease body weight loss and reduce the amount of virus in the lung. In addition to activity against coronaviruses, Molnupiravir, in laboratory studies, has demonstrated activity against seasonal and bird influenza, respiratory syncytial virus, chikungunya virus, Ebola virus, Venezuelan equine encephalitis virus, and Eastern equine encephalitis virus. Molnupiravir was originally developed to treat influenza at Emory University by the university’s drug innovation company, Drug Innovation Ventures at Emory (DRIVE), but was reportedly abandoned for mutagenicity concerns. It was then acquired by Miami-based company Ridgeback Biotherapeutics, which later partnered with Merck & Co. to develop the drug further. Molnupiravir was approved for medical use in the United Kingdom in November 2021.

Product detail pictures:

2021 Latest Design Narcotine Hydrochloride - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu detail pictures

Related Product Guide:
Attaining consumer satisfaction is our company's purpose without end. We will make wonderful endeavours to produce new and top-quality merchandise, satisfy your exclusive requirements and supply you with pre-sale, on-sale and after-sale services for 2021 Latest Design Narcotine Hydrochloride - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu , The product will supply to all over the world, such as: Namibia, Pretoria, Auckland, Certainly, competitive price, suitable package and timely delivery will be assured as per customers' demands. We sincerely hope to build business relationship with you on the basis of mutual benefit and profit in the very near future. Warmly welcome to contact us and become our direct cooperators.
    • Superb technology, perfect after-sales service and efficient work efficiency, we think this is our best choice.
    5 Stars By Victor Yanushkevich from Yemen - 2017.06.22 12:49
    Although we are a small company, we are also respected. Reliable quality, sincere service and good credit, we are honored to be able to work with you!
    5 Stars By Doris from Cape Town - 2018.09.29 13:24
    Write your message here and send it to us